Literature DB >> 26192563

Intermediate- and Long-Term Cognitive Outcomes After Cardiovascular Procedures in Older Adults: A Systematic Review.

Howard A Fink, Laura S Hemmy, Roderick MacDonald, Maureen H Carlyle, Carin M Olson, Maurice W Dysken, J Riley McCarten, Robert L Kane, Santiago A Garcia, Indulis R Rutks, Jeannine Ouellette, Timothy J Wilt.   

Abstract

BACKGROUND: Risks for intermediate- and long-term cognitive impairment after cardiovascular procedures in older adults are poorly understood.
PURPOSE: To summarize evidence about cognitive outcomes in adults aged 65 years or older at least 3 months after coronary or carotid revascularization, cardiac valve procedures, or ablation for atrial fibrillation. DATA SOURCES: MEDLINE, Cochrane, and Scopus databases from 1990 to January 2015; ClinicalTrials.gov; and bibliographies of reviews and eligible studies. STUDY SELECTION: English-language trials and prospective cohort studies. DATA EXTRACTION: One reviewer extracted data, a second checked accuracy, and 2 independently rated quality and strength of evidence (SOE). DATA SYNTHESIS: 17 trials and 4 cohort studies were included; 80% of patients were men, and mean age was 68 years. Cognitive function did not differ after the procedure between on- and off-pump coronary artery bypass grafting (CABG) (n = 6; low SOE), hypothermic and normothermic CABG (n = 3; moderate to low SOE), or CABG and medical management (n = 1; insufficient SOE). One trial reported lower risk for incident cognitive impairment with minimal versus conventional extracorporeal CABG (risk ratio, 0.34 [95% CI, 0.16 to 0.73]; low SOE). Two trials found no difference between surgical carotid revascularization and carotid stenting or angioplasty (low and insufficient SOE, respectively). One cohort study reported increased cognitive decline after transcatheter versus surgical aortic valve replacement but had large selection and outcome measurement biases (insufficient SOE). LIMITATIONS: Mostly low to insufficient SOE; no pertinent data for ablation; limited generalizability to the most elderly patients, women, and persons with substantial baseline cognitive impairment; and possible selective reporting and publication bias.
CONCLUSION: Intermediate- and long-term cognitive impairment in older adults attributable to the studied cardiovascular procedures may be uncommon. Nevertheless, clinicians counseling patients before these procedures should discuss the uncertainty in their risk for adverse cognitive outcomes. PRIMARY FUNDING SOURCE: Agency for Healthcare Research and Quality.

Entities:  

Mesh:

Year:  2015        PMID: 26192563     DOI: 10.7326/M14-2793

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN: 0003-4819            Impact factor:   25.391


  12 in total

1.  The Fallacy of Persistent Postoperative Cognitive Decline.

Authors:  Michael S Avidan; Alex S Evers
Journal:  Anesthesiology       Date:  2016-02       Impact factor: 7.892

2.  Risk factors for delirium after cardiac surgery: a historical cohort study outlining the influence of cardiopulmonary bypass.

Authors:  Jason B O'Neal; Frederic T Billings; Xulei Liu; Matthew S Shotwell; Yafen Liang; Ashish S Shah; Jesse M Ehrenfeld; Jonathan P Wanderer; Andrew D Shaw
Journal:  Can J Anaesth       Date:  2017-07-17       Impact factor: 5.063

Review 3.  Cerebral Oximetry and Autoregulation during Cardiopulmonary Bypass: A Review.

Authors:  Nousjka P A Vranken; Patrick W Weerwind; Nadia A Sutedja; Ervin E Ševerdija; Paul J C Barenbrug; Jos G Maessen
Journal:  J Extra Corpor Technol       Date:  2017-09

Review 4.  State of the clinical science of perioperative brain health: report from the American Society of Anesthesiologists Brain Health Initiative Summit 2018.

Authors:  Elizabeth Mahanna-Gabrielli; Katie J Schenning; Lars I Eriksson; Jeffrey N Browndyke; Clinton B Wright; Deborah J Culley; Lis Evered; David A Scott; Nae Yah Wang; Charles H Brown; Esther Oh; Patrick Purdon; Sharon Inouye; Miles Berger; Robert A Whittington; Catherine C Price; Stacie Deiner
Journal:  Br J Anaesth       Date:  2019-08-19       Impact factor: 9.166

Review 5.  Assessing Risks and Benefits of Invasive Cardiac Procedures in Patients with Advanced Multimorbidity.

Authors:  Ariela R Orkaby; Daniel E Forman
Journal:  Clin Geriatr Med       Date:  2016-02-12       Impact factor: 3.076

6.  Persistent cognitive deficits and neuroinflammation in a rat model of cardiopulmonary bypass.

Authors:  Yi Wang; Carlos Tache-Leon; Maro G Machizawa; Turner Lisle; Cedric Williams; Ryon H Clarke; Matthew J Anzivino; Irving Kron; Kevin S Lee
Journal:  J Thorac Cardiovasc Surg       Date:  2020-01-08       Impact factor: 5.209

Review 7.  Cerebral Hypoxia: Its Role in Age-Related Chronic and Acute Cognitive Dysfunction.

Authors:  Brina Snyder; Stephanie M Simone; Tania Giovannetti; Thomas F Floyd
Journal:  Anesth Analg       Date:  2021-06-01       Impact factor: 6.627

8.  Predictors of new-onset atrial fibrillation in elderly patients with coronary artery disease after coronary artery bypass graft.

Authors:  Rubanenko O Anatoĺevna; Fatenkov O Veniaminovich; Khokhlunov S Mikhaylovich
Journal:  J Geriatr Cardiol       Date:  2016-07       Impact factor: 3.327

9.  Subacute Subclinical Brain Infarctions after Transcatheter Aortic Valve Implantation Negatively Impact Cognitive Function in Long-Term Follow-Up.

Authors:  Alexander Ghanem; Jonas Dörner; Leonie Schulze-Hagen; Andreas Müller; Marius Wilsing; Jan-Malte Sinning; Julian Lütkens; Christian Frerker; Karl-Heinz Kuck; Ingo Gräff; Hans Schild; Nikos Werner; Eberhard Grube; Georg Nickenig
Journal:  PLoS One       Date:  2017-01-05       Impact factor: 3.240

10.  The Relationship of Coronary Artery Calcium and Clinical Coronary Artery Disease with Cognitive Function: A Systematic Review and Meta-Analysis.

Authors:  Congying Xia; Marleen Vonder; Grigory Sidorenkov; Matthijs Oudkerk; Jan Cees de Groot; Pim van der Harst; Geertruida H de Bock; Peter Paul De Deyn; Rozemarijn Vliegenthart
Journal:  J Atheroscler Thromb       Date:  2020-02-15       Impact factor: 4.928

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.